awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35194626-BF9C2644-F1DB-48C8-908C-1F54CA263A95
Q35194626-BF9C2644-F1DB-48C8-908C-1F54CA263A95
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35194626-BF9C2644-F1DB-48C8-908C-1F54CA263A95
The investigational Aurora kinase A inhibitor alisertib (MLN8237) induces cell cycle G2/M arrest, apoptosis, and autophagy via p38 MAPK and Akt/mTOR signaling pathways in human breast cancer cells
P2860
Q35194626-BF9C2644-F1DB-48C8-908C-1F54CA263A95
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35194626-BF9C2644-F1DB-48C8-908C-1F54CA263A95
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
30bf7d9a8d1af5ceb96a55b52cc6e7e36c28c29f
P2860
Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma.